Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Sun Pharma Advanced Research Company
Start SIPSun Pharma Advanced Research Company F&O
Sun Pharma Advanced Research Company Investment Rating
-
Master Rating:
-
Sun Pharma Advd.Resh. has an operating revenue of Rs. 216.33 Cr. on a trailing 12-month basis. An annual revenue de-growth of -44% needs improvement, Pre-tax margin of -148% needs improvement, ROE of -651% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 21 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 153 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 131 | 32 | 28 | 25 |
| Operating Expenses Qtr Cr | 115 | 94 | 107 | 92 |
| Operating Profit Qtr Cr | 16 | -63 | -78 | -67 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 |
| Interest Qtr Cr | 3 | 3 | 2 | 2 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 10 | -68 | -82 | -71 |
Sun Pharma Advanced Research Company Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 179.59
- 50 Day
- 192.05
- 100 Day
- 204.3
- 200 Day
- 217.61
- 20 Day
- 182.2
- 50 Day
- 192.96
- 100 Day
- 213.35
- 200 Day
- 216.44
Sun Pharma Advanced Research Company Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 165.9 |
| Second Resistance | 168.5 |
| Third Resistance | 170.4 |
| RSI | 28.43 |
| MFI | 14.17 |
| MACD Single Line | -6.47 |
| MACD | -8.67 |
| Support | |
|---|---|
| First Resistance | 161.4 |
| Second Resistance | 159.5 |
| Third Resistance | 156.9 |
Sun Pharma Advanced Research Company Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 292,653 | 13,342,050 | 45.59 |
| Week | 434,358 | 17,105,026 | 39.38 |
| 1 Month | 491,293 | 15,515,043 | 31.58 |
| 6 Month | 690,568 | 16,628,876 | 24.08 |
Sun Pharma Advanced Research Company Result Highlights
Sun Pharma Advanced Research Company Synopsis
NSE-Medical-Biomed/Biotech
Sun Pharma Advanced is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 137.25 Cr. and Equity Capital is Rs. 27.19 Cr. for the Year ended 31/03/2022. Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837.| Market Cap | 5,286 |
| Sales | 216 |
| Shares in Float | 11.03 |
| No of funds | 81 |
| Yield |
| Book Value | 141.65 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | |
| Alpha | -0.17 |
| Beta | 1.29 |
Sun Pharma Advanced Research Company
| Owner Name | Jan-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 65.67% | 68.22% | 69.09% | |
| Mutual Funds | 0.21% | 0.25% | 0.24% | |
| Foreign Portfolio Investors | 3.54% | 3.48% | 2.38% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 16.34% | 16% | 15.7% | |
| Others | 14.24% | 12.05% | 12.59% |
Sun Pharma Advanced Research Company Management
| Name | Designation |
|---|---|
| Mr. Dilip S Shanghvi | Chairman |
| Dr. T Rajamannar | Non Executive Director |
| Dr. Robert J Spiegel | Non Executive Director |
| Mr. Sudhir V Valia | Non Executive Director |
| Ms. Bhavna Doshi | Independent Director |
| Dr. Ferzaan Engineer | Independent Director |
Sun Pharma Advanced Research Company Forecast
Price Estimates
Sun Pharma Advanced Research Company FAQs
What is Share Price of Sun Pharma Advanced Research Company ?
Sun Pharma Advanced Research Company share price is ₹162 As on 23 March, 2023 | 00:38
What is the Market Cap of Sun Pharma Advanced Research Company ?
The Market Cap of Sun Pharma Advanced Research Company is ₹5286.5 Cr As on 23 March, 2023 | 00:38
What is the P/E ratio of Sun Pharma Advanced Research Company ?
The P/E ratio of Sun Pharma Advanced Research Company is -25 As on 23 March, 2023 | 00:38
What is the PB ratio of Sun Pharma Advanced Research Company ?
The PB ratio of Sun Pharma Advanced Research Company is 169.3 As on 23 March, 2023 | 00:38